Vol. 1 No. 3 (2022): Volume 1 Issue 3

Articles

• Proposing Vascepa (Icosapent Ethyl) as Supplemental Treatment Targeting the Underlying Causes of Persistent, Post-Viral SymptomsAssociated with COVID-19: A Case Series

  Sonya Peregrim BS, Lianne Ryan AB, Zuby Syed MD, Ivan Urits, MD, Omar Viswanath, MD, Alan D Kaye, MD, PhD, Jonathan P. Eskander, MD, MBA (Author)

  1-4

  • View PDF

• Returning Home after Migration

  Ines Estrada Vigil (Author)

  1-1

  • View PDF